Testing effectiveness (Phase 2)Study completedNCT02317393
What this trial is testing
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Who this might be right for
Non-seminomatous Germ Cell TumorsMetastasis
Centre Francois Baclesse 16